Lin Yuan-Feng, Lee Horng-Mo, Leu Sy-Jye, Tsai Yu-Hui
Graduate Institute of Pharmaceutical Science, Taipei Medical University, Taipei, Taiwan.
J Cell Biochem. 2007 Oct 1;102(2):429-41. doi: 10.1002/jcb.21305.
Human peripheral CD14(+)monocytes have been known to differentiate into monocyte-derived macrophages (MDMs) or dendritic cells (MoDCs) upon suitable stimulation. However, the key intracellular molecule(s) associated with their differentiation towards specific cell types was(were) not fully understood. This study was designated to determine the association of PKC isoenzymes with the differentiation of CD14(+)monocytes into MDMs or MoDCs. Purified human peripheral CD14(+)monocytes were cultured with GM-CSF, or GM-CSF plus IL-4 for 7 days to induce cell differentiation. The phenotypic changes were analyzed by Flow-Cytometry using various specific antibodies to cell type-specific surface markers. The immunological functions of these differentiated cells were determined by measuring the amounts of TNF-alpha secretion for MDMs, and the capacities of antigen-capturing and bacterial phagocytosis for MoDCs. The translocations of PKC isoenzymes in these cells from cytosol to plasma membrane were examined by Western Blot analysis and Confocal Microscopic observation. The treatment of CD14(+)monocytes with either GM-CSF or PMA elicited PKCalpha translocation and consequently induced their differentiation into MDMs. The inclusion of PKCalpha/beta(I) specific inhibitor, Go6976, greatly inhibited the GM-CSF-induced PKCalpha translocation and dose-dependently reduced the GM-CSF- induced MDM differentiation. On the other hand, the simultaneous pretreatment of CD14(+)monocytes with Go6976 and PKCbeta-specific inhibitor predominantly suppressed the GM-CSF/IL-4-induced generation of MoDCs. Further study demonstrated that GM-CSF/IL-4 selectively induced the translocation of PKCbeta(I), not PKCalpha or PKCbeta(II), in CD14(+)monocytes. In conclusion, the cell fate commitment of CD14(+)monocytes towards MDMs or MoDCs appears to be steered by the selective activation of PKCalpha or PKCbeta(I), respectively.
已知人类外周血CD14(+)单核细胞在适当刺激下可分化为单核细胞衍生的巨噬细胞(MDMs)或树突状细胞(MoDCs)。然而,与它们向特定细胞类型分化相关的关键细胞内分子尚未完全明确。本研究旨在确定蛋白激酶C(PKC)同工酶与CD14(+)单核细胞分化为MDMs或MoDCs之间的关联。将纯化的人类外周血CD14(+)单核细胞与粒细胞-巨噬细胞集落刺激因子(GM-CSF)或GM-CSF加白细胞介素-4(IL-4)培养7天以诱导细胞分化。使用针对细胞类型特异性表面标志物的各种特异性抗体,通过流式细胞术分析表型变化。通过测量MDMs分泌的肿瘤坏死因子-α(TNF-α)量以及MoDCs的抗原捕获和细菌吞噬能力,确定这些分化细胞的免疫功能。通过蛋白质印迹分析和共聚焦显微镜观察,检测这些细胞中PKC同工酶从细胞质到质膜的转位。用GM-CSF或佛波酯(PMA)处理CD14(+)单核细胞可引起PKCα转位,从而诱导它们分化为MDMs。加入PKCα/β(I)特异性抑制剂Go6976可极大地抑制GM-CSF诱导的PKCα转位,并剂量依赖性地降低GM-CSF诱导的MDM分化。另一方面,用Go6976和PKCβ特异性抑制剂同时预处理CD14(+)单核细胞,主要抑制GM-CSF/IL-4诱导的MoDCs生成。进一步研究表明,GM-CSF/IL-4在CD14(+)单核细胞中选择性诱导PKCβ(I)转位,而非PKCα或PKCβ(II)。总之,CD14(+)单核细胞向MDMs或MoDCs的细胞命运决定似乎分别由PKCα或PKCβ(I)的选择性激活所引导。